Combination therapy for Parkinson's disease

Details Combination therapy for Parkinson's disease Combination therapy for Parkinson's disease

1971-03-18

1976-11-09

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Recombinant or stably-transformed bacterium encoding one or...

260574, 260575, 424330, A61K 3120

Patent

active

039912078

ABSTRACT:
Substituted 1,2,3,4-tetrahydro-1-naphthylamines, or their acid addition salts, as potentiating agents in combination therapy with L-Dopa for control of the symptoms of Parkinson's disease. N,N-Dimethyl-5-methoxy-8-chloro-1,2,3,4-tetrahydro-1-naphthylamine is the preferred embodiment.

REFERENCES:
patent: 3462534 (1969-08-01), Greenlard et al.
patent: 3557292 (1971-01-01), Bartholini
patent: 3579582 (1971-05-01), Symon
J. Med. Chem. 9, 830-832 (1966).
Merck Index 8th ed. p. 699 (1968).

Affiliated with

Also associated with

Rating

Combination therapy for Parkinson's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy for Parkinson's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for Parkinson's disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1725990